脑室-腹腔分流术治疗HIV相关隐球菌性脑膜炎颅内高压

doi:10.3877/cma.j.issn.2095-9141.2021.02.009

中华神经创伤外科电子杂志 ›› 2021, Vol. 07 ›› Issue (02) : 103 -106. doi: 10.3877/cma.j.issn.2095-9141.2021.02.009

所属专题：文献；

颅脑创伤

脑室-腹腔分流术治疗HIV相关隐球菌性脑膜炎颅内高压

崔亚辉¹, 陈海平¹, 张海鹏¹, 胡昕¹, 喻剑华², 张忠东², 张斌海², 师金川², 闫俊², 张建民³^,^†(

)

^1. 310023　杭州，浙江大学医学院附属杭州市西溪医院神经外科
^2. 310023　杭州，浙江大学医学院附属杭州市西溪医院感染二科
^3. 310009　杭州，浙江大学医学院附属第二医院神经外科

收稿日期:2021-01-19 出版日期:2021-04-15
通信作者: 张建民
基金资助:
广元市科技计划项目(20ZDYF0037)

Ventriculo peritoneal shunt for intracranial hypertension in HIV-associated cryptococcus meningitis

Yahui Cui¹, Haiping Chen¹, Haipeng Zhang¹, Xin Hu¹, Jianhua Yu², Zhongdong Zhang², Binhai Zhang², Jinchuan Shi², Jun Yan², Jianming Zhang³^,^†()

^1. Department of Neurosurgery, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou 310023, China
^2. Second Department of Infection Disease, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou 310023, China
^3. Department of Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China

Received:2021-01-19 Published:2021-04-15
Corresponding author: Jianming Zhang

全文 ( ) 下载PDF ( ) 导出引用

引用本文：

崔亚辉, 陈海平, 张海鹏, 胡昕, 喻剑华, 张忠东, 张斌海, 师金川, 闫俊, 张建民. 脑室-腹腔分流术治疗HIV相关隐球菌性脑膜炎颅内高压[J/OL]. 中华神经创伤外科电子杂志, 2021, 07(02): 103-106.

Yahui Cui, Haiping Chen, Haipeng Zhang, Xin Hu, Jianhua Yu, Zhongdong Zhang, Binhai Zhang, Jinchuan Shi, Jun Yan, Jianming Zhang. Ventriculo peritoneal shunt for intracranial hypertension in HIV-associated cryptococcus meningitis[J/OL]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2021, 07(02): 103-106.

目的

观察脑室-腹腔（V-P）分流术治疗人类免疫缺陷病毒（HIV）相关隐球菌性脑膜炎（CM）颅内高压的临床疗效。

方法

回顾性分析浙江大学医学院附属杭州市西溪医院感染二科自2015年5月至2019年4月收治的59例HIV相关CM患者的临床资料，其中10例因颅内压高行V-P分流术，同时按指南给予规范的两性霉素B、氟胞嘧啶、氟康唑、伊曲康唑等抗真菌治疗，以颅内压以及颅高压症状改善为观察指标。

结果

所有分流患者术后均停用甘露醇、甘油果糖等降颅压药物，监测颅内压均低于200 mmH₂O（1 mmH₂O=0.0098 kPa）。患者术后头痛、呕吐、意识障碍、癫痫、视乳头水肿等均明显好转。

结论

HIV相关隐球菌性脑膜炎颅内高压需早期积极控制，腰大池引流管放置时间13 d是安全的。早期V-P分流可以有效降低颅内压，改善临床症状，降低死亡率。

关键词: 人类免疫缺陷病毒, 隐球菌性脑膜炎, 颅高压, 脑室-腹腔分流

Objective

To explore the clinical efficacy of ventriculo peritoneal (V-P) shunt for intracranial hypertension in human immunodeficiency virus (HIV)-associated cryptococcus meningitis (CM).

Methods

A retrospective analysis was conducted on the data of 59 HIV-associated CM patients in the Second Department of Infection Disease, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine from May 2015 to April 2019. Among those patients, 10 cases underwent V-P shunt due to intracranial hypertension, meanwhile underwent antifungal therapy including amphotericin B, flucytosine, fluconazole and itraconazole was given according to the guidelines. The intracranial pressure and alleviation of intracranial hypertension symptoms were taken as observation indexes.

Results

All patients with shunt were stopped with mannitol, glycerin fructose and other drugs, and the intracranial pressure was lower than 200 mmH₂O (1 mmH₂O=0.0098 kPa). The headache, vomiting, consciousness disorder, epilepsy, optic papilledema were all improved significantly.

Conclusion

Intracranial hypertension in HIV-associated cryptococcus meningitis should be aggressively treated at early time. It might be safety that placing the lumbago cistern drainage tube for 13 d. Intracranial pressure could be efficiently decreased by V-P shunt in early phase, which could also improve the clinical symptoms and reduce the death rate.

Key words: Human immunodeficiency virus, Cryptococcus meningitis, Cranial hypertension, Ventriculo peritoneal shunt

表1 10例HIV感染合并CM患者的临床资料

患者	性别	年龄（岁）	术前测压（mmH₂O）	术前脑脊液蛋白（mg/L）	发病到分流周期（d）	三脑室最大横径减小（mm)
1	男	37	>400	1794	39	2.4
2	男	28	>400	378	73	0.4
3	男	32	>400	853	20	1.0
4	女	52	300	2280	35	1.2
5	男	27	>400	205	11	1.9
6	男	34	>400	736	30	1.2
7	男	31	300	490	44	1.0
8	女	42	>400	206	43	1.0
9	男	38	350	652	90	1.0
10	男	31	>400	830	145	0.4

表1 10例HIV感染合并CM患者的临床资料

患者	性别	年龄（岁）	术前测压（mmH₂O）	术前脑脊液蛋白（mg/L）	发病到分流周期（d）	三脑室最大横径减小（mm)
1	男	37	>400	1794	39	2.4
2	男	28	>400	378	73	0.4
3	男	32	>400	853	20	1.0
4	女	52	300	2280	35	1.2
5	男	27	>400	205	11	1.9
6	男	34	>400	736	30	1.2
7	男	31	300	490	44	1.0
8	女	42	>400	206	43	1.0
9	男	38	350	652	90	1.0
10	男	31	>400	830	145	0.4

图1 典型患者术前术后的影像学资料

[1]	Rajasingham R, Smith RM, Park BJ, at el. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis[J]. Lancet Infect Dis, 2017, 17(8): 873-881.
[2]	Govender NP, Roy M, Mendes JF, et al. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa[J]. HIV Med, 2015, 16(8): 468-476.
[3]	Moore DM, Mermin J, Awor A, et al. Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings[J]. J Acquir Immune Defic Syndr, 2006, 43(4): 436-439.
[4]	Mfinanga S, Chanda D, Kivuyo SL, et al. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial[J]. Lancet, 2015, 385(9983): 2173-2182.
[5]	Pyrgos V, Seitz AE, Steiner CA, et al. Epidemiology of cryptococcal meningitis in the US: 1997-2009[J]. PLoS One, 2013, 8(2): e56269.
[6]	常健博，吴昊，魏俊吉.隐球菌脑膜炎并发颅内压增高的诊治进展[J].中国医学科学院学报, 2019, 41(1): 111-117.
[7]	Park MK, Hospenthal DR, Bennett JE. Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting[J]. Clin Infect Dis, 1999, 28(3): 629-633.
[8]	Robertson EJ, Najjuka G, Rolfes MA, et al. Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis[J]. J Infect Dis, 2014, 209(1): 74-82.
[9]	Loyse A, Wainwright H, Jarvis JN, et al. Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure[J]. AIDS, 2010, 24(3): 405-410.
[10]	Petrou P, Moscovici S, Leker RR, et al. Ventriculoperitoneal shunt for intracranial hypertension in cryptococcal meningitis without hydrocephalus[J]. J Clin Neurosci, 2012, 19(8): 1175-1176.
[11]	滕泽，王伟，关湘萍，等.大脑类淋巴系统的研究进展[J].中华老年心脑血管病杂志, 2017, 19(9): 1001-1003.
[12]	Lee SC, Casadevall A, Dickson DW. Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis[J]. Am J Pathol, 1996, 148(4): 1267-1274.
[13]	Srichatrapimuk S, Sungkanuparph S. Integrated therapy for HIV and cryptococcosis. AIDS Res Ther, 2016, 13(1): 42.
[14]	Chang CC, Perfect JR. Repeated therapeutic lumbar punctures in cryptococcal meningitis-necessity and/or opportunity?[J]. Curr Opin Infect Dis, 2016, 29(6): 539-545.
[15]	Beardsley J, Wolbers M, Kibengo FM, et al. Adjunctive dexamethasone in HIV-associated cryptococcal meningitis[J]. N Engl J Med, 2016, 374(6): 542-554.
[16]	Newton PN, Thai LH, Tip NQ, et al. A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis[J]. Clin Infect Dis, 2002, 35(6): 769-772.
[17]	Manosuthi W, Sungkanuparph S, Chottanapund S, et al. Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitis[J]. Int J STD AIDS, 2008, 19(4): 268-271.
[18]	Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america[J]. Clin Infect Dis, 2010, 50(3): 291-322.
[19]	Cherian J, Atmar RL, Gopinath SP. Shunting in cryptococcal meningitis[J]. J Neurosurg, 2016, 125(1): 177-186.
[20]	Woodworth GF, McGirt MJ, Williams MA, et al. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis[J]. Surg Neurol, 2005, 63(6): 529-531; discussion 531-532.
[21]	赵杰，刘景平，张治平，等.分流手术治疗新型隐球菌性脑膜炎的体会与文献回顾[J].中南大学学报(医学版), 2016, 41(5): 541-547.

[1]	杨桂清, 孟静静. 哺乳期亚临床乳腺炎的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 376-379.
[2]	吴茜, 邓力, 练士贤, 张华, 江颖, 张宏伟. 伴人类免疫缺陷病毒感染乳腺癌患者的临床病理特征与预后的相关性研究[J/OL]. 中华乳腺病杂志(电子版), 2023, 17(03): 151-156.
[3]	丁兴欢, 王小永, 李风志, 梁博, 冯恩山. 颅内外血管搭桥联合贴敷治疗慢性颈内动脉闭塞的人类免疫缺陷病毒感染者一例及文献复习[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 314-319.
[4]	熊企秋, 邢卉春, 李宝亮, 王杨, 贾哲, 张珂, 黄容海, 蒋力. 人类免疫缺陷病毒感染对肛瘘患者接受切开挂线术治疗预后的影响[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 303-308.
[5]	戚仕轩, 阮连国. 人类免疫缺陷病毒感染快速启动抗逆转录病毒治疗研究及模式探索[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 193-199.
[6]	曾雪灵, 杨思园, 常宇飞, 赵红心, 王凌航. 176例人类免疫缺陷病毒合并肺部感染者呼吸道病原体特点与免疫学特征[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(03): 142-148.
[7]	叶俊杰, 胡波涌. 人类免疫缺陷病毒感染者限期骨折内植物手术并发症的影响因素[J/OL]. 中华实验和临床感染病杂志(电子版), 2023, 17(06): 423-430.
[8]	陈珂, 孙挥宇. 人类免疫缺陷病毒感染/获得性免疫缺陷综合征患者非感染性相关眼病研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2023, 17(06): 395-399.
[9]	张玉, 薛文瑞, 王鑫, 李旭瑜, 王旭东, 袁鹏飞, 梁雨润, 韩志兴, 张海建, 刘庆军, 纪世琪. 人类免疫缺陷病毒感染合并膀胱癌14例临床特点[J/OL]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 354-358.
[10]	崔贵香, 丁晓燕, 褚盈晖, 孙代, 吴海燕, 陈京龙. 57例人类免疫缺陷病毒感染合并Burkkit淋巴瘤患者的临床分析[J/OL]. 中华实验和临床感染病杂志(电子版), 2023, 17(02): 102-109.
[11]	袁瑞, 胡文佳, 桂希恩, 严亚军, 冯玲, 柯亨宁, 熊勇, 杨蓉蓉. 淋巴细胞精细分型检测在人类免疫缺陷病毒感染者/获得性免疫缺陷综合征患者中的应用[J/OL]. 中华实验和临床感染病杂志(电子版), 2023, 17(02): 84-91.
[12]	张燕珍, 王锡携, 文小兰. 血清巨噬细胞迁移抑制因子对活动性肺结核分诊检测的意义[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(02): 200-202.
[13]	陈浪, 陈玉静, 肖恺, 陈阳, 邵强, 潘力, 胡飞, 王焕明, 陈俊, 徐豪. 脑室-腹腔分流术后脑脓肿一例报道并文献复习[J/OL]. 中华神经创伤外科电子杂志, 2023, 09(06): 378-380.
[14]	王希岗, 张波, 李鸣, 高敏, 薛建新. 神经外科手术部位感染在HIV感染者与非HIV感染者中的临床差异[J/OL]. 中华神经创伤外科电子杂志, 2023, 09(04): 228-233.
[15]	李佳佳, 李凌华, 吕诗韵, 冯凯, 刘琳珊, 钟海丹, 颜婵, 刘聪. 广州市病毒学抑制失败HIV/AIDS患者的耐药特征及影响因素分析[J/OL]. 中华卫生应急电子杂志, 2024, 10(04): 207-212.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Ventriculo peritoneal shunt for intracranial hypertension in HIV-associated cryptococcus meningitis

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Ventriculo peritoneal shunt for intracranial hypertension in HIV-associated cryptococcus meningitis